If you are wondering whether CRISPR Therapeutics at around US$53.52 is offering good value today, you are not alone. The stock often attracts investors who care about price versus potential. The share ...

Scientists have long sought to understand why some plants are fragrant powerhouses while others remain subtle. Now, a ...

CRISPR Therapeutics AG (NASDAQ: CRSP) stock is up more than 12% after the gene editing pioneer reported its Q4 2025 earnings on Feb. 13. At first glance, that may seem contradictory. The ...

DNA is the blueprint of life. Genes encode proteins and serve as the body's basic components. However, building a functioning ...

A groundbreaking CRISPR tool could reverse the global antibiotic resistance crisis. Could this be the end of superbugs?

Emerging technologies, increasing focus on R&D, and a growing demand in treating previously incurable diseases present significant opportunities across diverse applications and regions Cell & Gene ...

Humans have been shaping life for thousands of years through farming, breeding, and selective cultivation. But with modern tools like CRISPR, we can now directly edit DNA itself—rewriting the very ...

A new Crispr-powered optical blood test detects lung cancer biomarkers at sub-attomolar levels, offering earlier molecular detection than conventional PCR or imaging.

EDEN (short for environmentally-derived evolutionary network) processes evolutionary DNA from more than one million newly ...

And the presence of the Barcelona Science Park, which is the first science park in Spain that is home to three research institutes and more than 70 companies, make the city a viable location for ...

Antibiotic resistance is racing toward a global crisis, with “superbugs” projected to cause over 10 million deaths annually by 2050. Now, scientists at UC San Diego have unveiled a powerful new CRISPR ...

A golden apple snail can regrow a complete camera-type eye in 30 days, offering new clues into genetic pathways that may one day help restore human vision ...